SAFE PRO GROUP INC. Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- SAFE PRO GROUP INC. shares issued, shares, share-based payment arrangement, after forfeiture for the quarter ending 2024-12-31 was 0.00 shares.
- SAFE PRO GROUP INC. shares issued, shares, share-based payment arrangement, after forfeiture for the quarter ending 2024-09-30 was 0.00 shares.
- SAFE PRO GROUP INC. shares issued, shares, share-based payment arrangement, after forfeiture for fiscal 2025 was 450.00K shares, a 0.00% change from fiscal 2024.
- SAFE PRO GROUP INC. shares issued, shares, share-based payment arrangement, after forfeiture for fiscal 2024 was 450.00K shares.
| Period end | Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture 3 month | Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture 12 month |
|---|---|---|
| 2025-12-31 | 450.00K shares 10-K · filed 2026-03-31 | |
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | 450.00K shares 10-K · filed 2025-03-31 |
| 2024-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |
| Envoy Medical, Inc. (COCH) | United States | $0.056B | |
| ALPHA PRO TECH LTD (APT) | $0.052B | 13.63 | |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| MILESTONE SCIENTIFIC INC. (MLSS) | United States | $0.036B | -6.85 |
| Lifeward Ltd. (LFWD) | $0.021B | ||
| ENvue Medical, Inc. (FEED) | United States | $0.011B |